Sigma Nutrition Radio

Living longer does not necessarily mean spending more years in good health. But how much of the decline we associate with aging is inevitable, and how much reflects disease, inactivity, and other potentially modifiable factors Nutrition presents a particular challenge in later life: energy requirements often fall, while the need for many nutrients remains unchanged or increases. How should we interpret claims about protein, plant-based diets, supplements, and bone health? To discuss this is Prof. Charlyn Black, a long-time health services and policy researcher at the University of British Columbia, whose work includes the prevention of chronic disease and the role of nutrition in healthy aging. Timestamps [02:42] Interview start [05:38] Chronic disease burden [07:16] Healthspan versus lifespan [09:09] Modifiable ageing factors [13:35] Start early but its never too late [17:12] Diet patterns with most evidence [20:54] Nutrients of concern for older adults [27:31] Bone health [30:55] Policy and food environments [34:28] Key ideas Links: Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Book: Plant Powered Seniors

Can broad-spectrum vitamin and mineral supplements improve anxiety, depression or emotional regulation?  In this Premium-exclusive episode, we examine three randomised, placebo-controlled trials from Professor Julia Rucklidge's research group: NoMAD, investigating anxiety and depressive symptoms in adults; NUTRIMUM, examining depressive symptoms during pregnancy; and BEAM, studying irritability and emotional dysregulation in adolescents. These studies offer an opportunity to explore some central challenges in interpreting nutrition and mental health research. What does "faster improvement" mean when groups reach similar outcomes by the end of a trial? How should improvements in overall functioning be weighed against results from depression-specific measures? And how much confidence should we place in a large treatment effect found within a small subgroup? Links: Go to episode page Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Studies discussed: NoMAD trial – Blampied et al., 2023 NUTRIMUM trial – Bradley et al., 2024 BEAM trial – Rucklidge et al., 2026 Related episodes: #117: Prof. Julia Rucklidge – Role of Micronutrients in Mental Health & Psychiatric Disorders #473: Diet & Depression (What Do We Actually Know?) – Nicole Lippman-Barile, PhD

Claims about "improving the gut microbiome" are widespread, but what would improvement actually mean?  How do we establish which microbial changes contribute to disease, and which simply reflect it? Research on bacterial metabolism of medications raises questions about how the microbiome might influence treatment efficacy and toxicity. What would it take to translate these findings into reliable tests and effective therapies? In this episode, gastroenterologist and researcher Prof. Harry Sokol examines these questions, discusses the development of Faecalibacterium prausnitzii as an investigational treatment, and considers what current evidence can tell us about dietary advice and commercial microbiome testing. Timestamps [02:50] Harry Sokol's work [04:36] Defining healthy microbiome [06:48] Do we have causal evidence? [11:05] FMT evidence [15:29] Diet-microbiome claims [20:45] Emulsifiers & IBD research [22:54] Microbiome-drug interactions [30:23] Bacteria as a drug? [38:09] Microbiome testing [44:36] Key ideas segment (Premium-only) Introduction Claims about "improving the gut microbiome" are widespread, but what would improvement actually mean?  How do we establish which microbial changes contribute to disease, and which simply reflect it? Research on bacterial metabolism of medications raises questions about how the microbiome might influence treatment efficacy and toxicity. What would it take to translate these findings into reliable tests and effective therapies? In this episode, gastroenterologist and researcher Prof. Harry Sokol examines these questions, discusses the development of Faecalibacterium prausnitzii as an investigational treatment, and considers what current evidence can tell us about dietary advice and commercial microbiome testing. Timestamps [02:50] Harry Sokol's work [04:36] Defining healthy microbiome [06:48] Do we have causal evidence? [11:05] FMT evidence [15:29] Diet-microbiome claims [20:45] Emulsifiers & IBD research [22:54] Microbiome-drug interactions [30:23] Bacteria as a drug? [38:09] Microbiome testing [44:36] Key ideas segment (Premium-only) On this episode: Host: Danny Lennon Guest: Prof. Harry Sokol Episode Resources: Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Exeliom Biosciences Book: MICROBIOME: Science, Promises and Lies Instagram: @harry_sokol LinkedIn: Prof. Harry Sokol

Can an athlete reduce the environmental impact of their diet while still meeting the demands of training, competition and recovery? Peter Res argues that these aims can be compatible, provided dietary changes are planned around the athlete's needs. The discussion looks at practical changes athletes can make to make their diets more environmentally sustainable. This includes tips on increasing the contribution of plant proteins, maintaining adequate energy intake, and making plant-rich eating practical within sporting environments. Timestamps [04:21] Peter Res' background [05:22] Defining sustainability metrics [08:17] Biggest diet change to make it more environmentally sustainable [09:23] Is local and organic actually better? [13:44] Athlete fears about protein [18:07] Barriers for athletes [19:37] Fueling high calorie needs [21:26] Micronutrients [24:02] Performance effects [26:32] Athletes as role models [30:17] Easy first steps [34:21] Premium-only: key ideas segment Links: Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course LinkedIn: Peter Res Fork Ranger Related episodes: #320: Hannah Ritchie, PhD – Environmental Impacts of our Diet: Climate, Carbon Footprint & Land Use #446: How Climate Change Impacts Nutrient Status #584: EAT-Lancet: Does the Planetary Health Diet Improve Human Health?  

Men commonly feel that if their testosteone isn't "optimized" and high, they are missing out on greater health in a variety of ways. But what can a testosterone result actually tell us? How can results be interpreted with appropriate nuance that is needed? How low is low enough to be problematic? In situations where a test flags testosterone as low, there is a belief this means automatically starting testosterone replacement therapy. While TRT can be an excellent intervention in appropriate cases, when is it actually likely to benefit someone, and when is it not? For many people the decision seems straightforward: get a blood test, see whether testosterone is a little low, and start TRT. However, this simplistic thinking is full of potential issues that are important to understand. Dr. Austin Baraki returns to discuss how testosterone testing should inform treatment decisions, what benefits to expect, and the questions surrounding fertility and long-term safety. Timestamps: [03:50] Dr Austin Baraki's work [06:33] When and why test? [10:36] Probability and context impacts interpretation [14:13] What labs measure [21:15] Specific vs nonspecific symptoms [28:35] Primary vs secondary hypogonadism [32:30] Lifestyle vs TRT decisions [35:21] TRT risks [39:32] Testing timing and variability [41:55] Androgen receptor genetics [44:28] Free vs total testosterone [48:57] Low-normal results: what now? [57:45] TRT risks?: heart and prostate [01:03:55] Side effects and monitoring Links: Go to episode page & resources Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Instagram: @austin_barbellmedicine Barbell Medicine McCormack & Holmes, 2020 – Your results may vary: the imprecision of medical measurements #417: Austin Baraki, MD – What Do Nutrient Blood Tests Actually Tell Us?: Understanding Biomarkers #334: Austin Baraki, MD – Potential Harms of Screening, Overdiagnosis and Overtreatment